Trial Profile
EFFICACY AND TOLERABILITY OF CHONDROITIN SULPHATE 1000MG, TWICE DAILY IN PATIENTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Nov 2018
Price :
$35
*
At a glance
- Drugs Chondroitin sulfate (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 14 Nov 2018 The trial has been completed in France (End Date;2011-07-04).
- 15 Mar 2012 Planned end date (Jun 2011) added as reported by European Clinical Trials Database.
- 14 Jun 2011 New trial record